Xeris Biopharma Holdings
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Xeris Biopharma Holdings's balance sheet done over the years? Its assets were worth $344,522,000 last year, which is more than in the previous period. 87% of Xeris Biopharma Holdings’s total assets is currently financed by debt. Its liabilities reached the amount of $299,335,000, which means an increase by 357% compared compared to last year.
Debt to Assets
| 2016 | 33533000 | 65.46M | 195.23% |
|---|---|---|---|
| 2022 | 344522000 | 299.33M | 86.88% |
XERS Balance Sheet (2017 – 2023)
| 2023 | 2017 | |
|---|---|---|
Assets | ||
Current assets: | ||
Cash and cash equivalents | 121.96M | 32.26M |
Short term investments | 0 | 0 |
Net receivables | 30.83M | 101K |
Inventory | 24.73M | 0 |
Other current assets | 9.28M | 804K |
Total current assets | 186.81M | 33.17M |
Non-current assets: | ||
Property, Plant and Equipment | 28.37M | 312K |
Goodwill | 120.60M | 0 |
Intangible assets | 3.99M | 0 |
Long term investments | 4.34M | 0 |
Other non-current assets | 267K | 47K |
Total non-current assets | 157.70M | 359K |
Total assets | 344.52M | 33.53M |
Liabilities | ||
| Current liabilities: | ||
Accounts payable | ||
Deferred revenue | 64.77M | 263K |
Short term debt | 3.16M | 0 |
Total current liabilities | 73.62M | 2.52M |
| Non-current liabilities: | ||
Long term debt | 196.47M | 0 |
Deferred tax | 0 | 0 |
Other non-current liabilities | 25.71M | 62.94M |
Total non-current liabilities | 225.71M | 62.94M |
Total liabilities | 299.33M | 65.46M |
| Data source |